B.Subtilis(Jinling Hospital)

N/A

Report date: 2024/09/26 20:00:05

Base Information

Drug NameB.Subtilis(Jinling Hospital)
Drug Alias NameMedilac-sS20030087
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsPurine-Pyrimidine Metabolism, Inborn ErrorsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJinling Hospital,Nanjing University,School MedicineBeijing Hanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJinling Hospital,Nanjing University,School Medicine
Inactive CompaniesN/A
Active IndicationsPurine-Pyrimidine Metabolism, Inborn ErrorsIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A